Key points are not available for this paper at this time.
RGDV-gemcitabine successively overcame the defects of gemcitabine and provided a practical strategy of nano-medicine.
Liu et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: